glp 1 shortages FDA Ends Compounding of GLP-1 Drugs as Improve, The U.S. Food and Drug Administration (FDA) has announced the end of the shortage for GLP-1 weight loss drugs like Ozempic, leading to the The GLP-1 drug shortage is

The Heavy Price of GLP-1 Drugs reveals how pharmaceutical companies are exploiting the patent system, delaying competition, and driving up costs for patients

GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone produced in the gut in response to eating

Conversely, this trend heralds a potential boom for producers of health-oriented products like protein shakes and meal replacements, indicating a realignment of consumer preferences towards weight-management foods

Encourages comfortable satiety so youre less tempted by extra snacks*

It's more evidence for what I write about in "Lies I Taught in Medical School": the metabolic dysfunction driving obesity is the same dysfunction driving depression, anxiety, and addiction